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ABSTRACT Receptor-mediated uptake and degradation of 1251-asialoorosomucoid (ASOR) in
human hepatoma HepG2 cells is inhibited by the lysosomotropic amines chloroquine and
primaquine. In the absence of added ligand at 37°C, these amines induce a rapid (t1/2 5.5-6
min) and reversible loss of cell surface "'I-ASOR binding sites as well as a rapid decrease in
125 1-ASOR uptake and degradation . There is no effect of these amines on the binding of "'I-
ASOR to the cell surface at 4°C or on the rate of internalization of prebound 1251-ASOR. The
loss of "'I-ASOR surface binding at 37°C is not attributable to altered affinity of ligand-
receptor binding. In the presence of added ligand at 37°C, there is a more rapid (t1/2 2.5-3
min) loss of hepatoma cell surface receptors. In addition, the amines inhibit the rapid return
of the internalized receptor to the cell surface. We examined the nature of this loss of
1251-
ASOR surface binding sites by following the fate of receptor molecules after biosynthetic
labeling and after cell surface iodination. At 37°C, chloroquine and primaquine induce a loss
of asialoglycoprotein receptor molecules from the hepatoma cell surface to an internal pool .
The selective uptake of macromolecular ligands such as pro-
teins via receptor-mediated endocytosis is a common feature
of eucaryotic cells (1, 2). Receptor-mediated endocytosis in-
volves the specific binding of macromolecular ligands (e.g.,
virus, toxin, transferrin, asialoglycoprotein) to specialized cell
surface receptors and their internalization via a coated pit-
coated vesicle pathway. Many ligands dissociate from their
receptor in a prelysosomal compartment and allow the recep-
tor to recycle back to the cell surface (1, 2). Often, these
ligands are then transported in a still unknown way to the
lysosomes, wherein they are degraded. The asialoglycoprotein
receptor (ASGP-R),' localized to the hepatic parenchymal
cell, provides a well-characterized system for examination of
the mechanisms involved in these processes (3). A human
hepatocyte-derived cell line, hepatoma HepG2, contains
abundant ASGP-R (4). Using these cultured cells as a model,
we have recently defined the kinetics of receptor-mediated
endocytosis of asialoglycoprotein ligands and ASGP-R recy-
cling (5, 6). Our studies indicate that a single ASGP-R can
recycle from the cell surface into "endosomal sorting com-
partments" (compartment of uncoupling receptor and ligand
' Abbreviations used in this paper. ASGP, asialoglycoprotein; ASGP-
R, ASGP receptor; ASOR, asialoorosomucoid.
[CURL]) within the cell and back to the cell surface within 8
min (5-7).
The mechanisms responsible for ligand-receptor dissocia-
tion and the sorting and recycling of receptor molecules are
not fully understood. Lysosomotropic agents (including the
weak bases ammonium chloride and chloroquine) have been
demonstrated to interfere with receptor-mediated uptake and
degradation of numerous ligands, including asialoglycopro-
teins (8), mannose-6-phosphate-terminatedligands (9), alpha-
2-macroglobulin-protease complexes (10), mannosylated al-
bumin (11),and low-density lipoproteins (12). Both lysosomes
(13) and endosomes (14, 15) are now knownto be acidic, and
the pH of both organelles can be raised by the presence of
lysosomotropic agents (16). Studies following the fate of la-
beled ligand suggest that the lysosomotropic agents interfere
with receptor recycling by sequestering receptor within intra-
cellular compartments (17).
The hepatoma ASGP-R is a well-characterized system with
which to examine the effects of the lysosomotropic amines
on receptor recycling, since both well-defined parameters for
ASGP-R recycling (5) and anti-human ASGP-R antibodies
(18) are available. In the present study we define the effects
of two lysosomotropic amines on the parameters of endocy-
tosis of asialoglycoprotein in cloned hepatoma HepG2 cells.
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surface binding sites. By following labeled receptor molecules,
we demonstrate that the amines induce a loss of cell surface
receptor to an internal pool. These data provide support for
the constitutive recycling of ASGP-R in HepG2 cells.
MATERIALS AND METHODS
Materials:
￿
Human orosomucoid, provided bythe American Red Cross,
was desialylated and iodinated with I'll as previously described (19). Chloro-
quine and primaquine were obtained from Sigma Chemical Company (St.
Louis, MO) as the biphosphate salts, and monensin was obtained from Calbi-
ochem-BehringCorp. (La Jolla, CA). All drug solutions were prepared fresh in
Eagle's minimal essential medium (Gibco Laboratories, Grand Island, NY) for
each experiment. The preparation and characterization ofaffinity-purified anti-
human ASGP-R antibodies has been described (l8).
Cells:
￿
The human hepatoma cell line HepG2 (clone a16) was used for
all studies reported here. Maintenance ofthese cells has been detailed earlier
(4, 18).
Binding, Uptake, Degradation, and Internalization Assays:
Thebinding of 'ZSI-asialoorosomucoid (ASOR) to HepG2 cells at 4°C has been
described; specific binding is defined as the difference of binding of 'ZSI-ASOR
in the absence and presence of excess unlabeled ASOR (4). Assays for the
uptake and degradationof"I-ASOR at 37°C havebeendescribed(5). However,
in the present study the medium used was Eagle's minimal essential medium/
10% fetal calf serum/10 mM Hepes (pH 7.3). In general, uptake was assayed
during a 2-h period at 37°C, a time period during which release of `D6I
degradation products into the medium is minimal (5). Degradation was gen-
erally assayed at 4 h at 37°C.
Internalization was assessed by evaluating the cell-associated, EDTA-non-
releasable "'I-ASOR within cells (5). Cells were exposed to "I-ASOR at 4°C
in order to saturate all surface receptors. Unbound "'I-ASOR was removed
and the cells were temperature-shifted to 37°C for various times and then
returned to 4°C. The cells were then treated for 5 min at 4°C with 10 mM
EDTA in PBS (pH 5). Both the I'll-ASOR released by this treatment (cell
surfaceligand) and that sequestered within thecells (EDTA-nonreleasable) were
determined (5).
Biosynthetic Labeling of Receptor:
￿
Biosynthetic labeling of hu-
man ASGP-R was performed using ["S]methionine asdetailed previously (l8).
Cells were labeled with 300 gCi of [SSS]methionine/ml for 60 min followed by
a 2-h chase period in the presence of 400-fold excess unlabeled methionine.
Immunoprecipitation of ASGP-R and Analysis by SDS
PAGE:
￿
After biosynthetic labeling and exposure to drugs, the cells were
chilled to 4°C. For the analysis of total cell receptor, cells were solubilized in
I% Triton X-100/1 mM phenylmethylsulfonyl fluoride in PBS and immuno-
precipitated with affinity-purified anti-human ASGP-R antibody as described
previously (18). Immune complexes were isolated with Staphylococcal protein
A, and the antigens and antibodies were separatedby SDS-PAGE andprepared
for fluorography with Enhance (New England Nuclear, Boston, MA) (18).
Densitometry was performed using a Helena Laboratories (Beaumont, TX)
Quickscan with integrator.
Immunoprecipitation of ASGP-R from the Cell Surface:
￿
As
described previously (l8), after the appropriate biosyntheticlabeling, cells were
chilled at 4°C, washed in PBS containing PMSF, and incubated for 3 h at 4°C
with affinity-purified anti-human ASGP-R (5-60 gg/ml in PBS/l mM PMSF
containing 0.1 mg/ml cytochrome c). Following removal of the unbound IgG,
the cells were solubilized in 1% Triton X-100/1 mM phenylmethylsulfonyl
fluoride/PBS containing a l0-fold excess of unlabeled cell extract (to prevent
surface IgG from binding intracellular labeled receptor, which became available
during solubilization). This material was subjected to immunoprecipitation
and analysis by SDS PAGE and fluorography (18).
Cell Surface Iodination:
￿
HepG2 cells were vectorally labeled with
'ZSI at 4°C as previously described(20). Briefly, 106 cellswere washed with PBS
and incubated for 15 min at 4°C with 1 mCi 'ZSI in the presence oflactoper-
oxidase and glucose oxidase. The cells were then washed, solubilized in 1 %
Triton X-100/1 mM phenylmethylsulfonyl fluoride/PBS, immunoprecipitated,
and analyzed on SDS PAGE.
RESULTS
In the absence of added ligand, chloroquine (1 mM) induces
a rapid loss ofhepatoma "'I-ASOR surface binding. At 37°C,
the half-time for depletion of surface binding sites is 5-6 min
(Fig. 1). The effect is similar to the decrease of surface ligand
binding of ASGP on isolated rat hepatocytes (8) and manno-
sylated BSA binding on alveolar macrophages (11). Identical
kinetics ofloss ofASGP surface binding was found with (0.2-
1 mM) primaquine (data not presented). Chloroquine (20-
200 AM) had minimal effects on the extent of "'I-ASOR
surface binding during a 2 .5-h incubation at 4°C (Fig. 2 a).
However, there was a dose-dependent loss of surface binding
in cells exposed to the drug at 37°C, which resulted in a 50%
inhibition (I5o) at -100 AM; the No was -400 AM (Fig. 2 a).
Similarly, primaquine had little if any effect on the saturation
binding of 'ZSI-ASOR during incubation at 4°C. Primaquine
also produced a dramatic effect at 37°C with an 150 of -70
AM and an I9o of 200 AM (Fig. 2a). Other primary amines,
e.g., ammonium chloride and methylamine, were found to
have similar but less potent effects (Table I). The carboxylic
cationic ionophore monensin similarly decreased "'I-ASOR
binding to hepatoma cells (Table I).
We also examined the effect of these drugs on the uptake
of 'ZSI-ASOR into hepatoma cells. We chose a period of 2 h
at 37°C, a time by which little internalized ligand has been
released into the media as degradation products (5). As seen
in Fig. 2 b, both chloroquine and primaquine induced a drug-
dependent reduction of ' ZSI-ASOR uptake (I50 -80 uM; I9o
-200 AM). Similar to the effects on surface binding and
uptake at 2 h, ' ZSI-ASOR degradation, assessed after 4 h at
37°C, was inhibited by both chloroquine and primaquine in
a dose-dependent manner (150 -40-50 AM for chloroquine
and 70 AM for primaquine; I9o 100 AM for chloroquine and
200 AM for primaquine) (Fig. 2e). Furthermore, identical
effects of inhibition of uptake and degradation were seen in
samples examined after20 h ofligand uptake and degradation
(data not presented). In addition, similar effects were seen
after exposure to ammonium chloride, methylamine, and
monensin (Table I).
Internalization ofsurface-bound `ZSI-ASOR was unaffected
by 200 AM primaquine or chloroquine (Fig. 3). The tZ of2-
2.2 min is identical to that reported earlier (5). However, the
extent of internalization of surface-bound 'ZSI-ASOR may be
reduced by 10% at longer incubation times (e.g., 10 min) (Fig.
3).
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FIGURE 1
￿
Time course of effect of chloroquine on '251-ASOR sur-
face binding to hepatoma cells. Hepatoma cells were rinsed in fresh
binding media and thereafter incubated at 37°C in the presence of
1 mM chloroquine. At the appropriate time, cells were rapidly (<5
s) chilled to 4°C, washed, and incubated with '251-ASOR in the
absence or presence of excess unlabeled ASOR to determine
specific binding. The results are expressed as percent of specific
binding by control samples that were not exposed to the drug; each
point represents the mean of 3-4 samples from each of four
independent experiments. The SEM was less than ± 15%.
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FIGURE 2
￿
Effect of chloroquine and primaquine on "'I-ASOR sur-
face binding, uptake and degradation in hepatoma cells. (A) Hepa-
toma cells were rinsed and incubated at either 4°C (") or 37°C (O)
for 30 min with various concentrations of drugs. Thereafter binding
of 121 1-ASOR was performed at 4'C in the absence or presence of
excess unlabeled ASOR to determine specific binding as described
in the text. The results are expressed as percent of specific binding
by control samples that were not exposed to drug; each point
represents the mean of two to four samples from a total of five
experiments. (e) Hepatoma cells were rinsed and incubated at 37°C
for 30 min with various concentrations of drugs. Thereafter "'I-
ASOR was added in absence or presence of excess unlabeled ASOR
and the incubation continued for 2 h. Total cell-associated 1211 was
determined as described in the text. The results are expressed as
in A. (C) Hepatoma cells were prepared and treated as in B, except
that incubation with "'I-ASOR was continued for 4 h . 1211-degra-
dation products in the media were determined as described in the
text. The results are expressed as in A.
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TABLE I
Effect ofAmmonium Chloride, Methylamine, and Monensin on
Surface Binding and Uptake of "'I-ASOR by Hepatoma Cells
Surface Binding
Cells were washed and preincubated with appropriate drugs for 30 min at
either 4 or 37°C. Thereafter, in the continued presence of drug, surface
binding (2 h x 4°C) or uptake (2 h x 37°C) was determined. Nonspecific
bindingand uptake was determined for each experimental condition and the
results of specific binding or uptake are presented as percent control ± SEM
for three determinations.
This inhibitory effect of chloroquine and primaquine on
the uptake of 'ZSI-ASOR in hepatoma cells is rapidly reversi-
ble. As seen in Table II, the removal of 200 AM primaquine
from the media after a 30-min preincubation at 37°C allowed
the uptake of 121I-ASOR to return to control values (94%) by
2 h at 37°C, while cells maintainedwith 200 ,M primaquine
at 37°C demonstrated only 8% control uptake. Furthermore,
replacement of primaquine with chloroquine at equimolar
concentrations during the uptake incubation demonstrated
that chloroquine was not as effective in maintaining the
inhibition of "'I-ASOR uptake, which is consistent with the
effects on surface binding and uptake seen in Fig. 2.
Since chloroquine and primaquine promotea loss ofsurface
ligand binding sites, in addition to reducing ligand degrada-
tion (Fig. 2), we examined which effect is observed first at
lower drug concentrations. In order to test this, cells were
incubated with various concentrations of primaquine (20-
200 AM) for 2 or 4 h at 37°C. Thereafter, we determined
binding (at 4°C), degraded ligand in media, total cell-associ-
ated ligand, and internalized ligand. A dose-dependent de-
crease in surface ligand binding and ligand degradation at 4
h was found (Table III) and was similar to that found earlier
(Fig. 2). It should be noted that the determination of surface
ligand binding is a static measurement and reflects only the
number of binding sites at the cell surface at the time ofassay,
in this instance after a 4-h incubation at 37°C with prima-
quine. In contrast, the total cell-associated ' ZSI-ASOR and
degradation reflect the overall uptake and processing ofligand
during 4 h. The total amount ofligand internalized decreased
only slightly to 93% of control in the presence of 40 AM
primaquine and to 83% of control in the presence of 70 AM
primaquine (Table III). Even at 100 AM primaquine, <30%
reduction in total ligand processed was found. However, at
primaquine concentrations of 20-70 pM, there was a substan-
Drug
Concen-
tration
mm
4°C prein-
cubation
37°C
preincuba-
tion
2-h uptake
37°C prein-
cubation
None - 100±5 100±5 100±6
Chloroquine 1 103 ± 10 34 ± 2 14 ± 4
0.1 94±6 79±8 54±4
NH4CI 10 93±18 62±8 48±3
1 - 85 ± 11 -
0.1 - 96±10 -
Methylamine 10 111 1 17 64 ± 8 53 ± 5
1 - 89 ± 13 -
0.1 - 92±10 -
Monensin 0.1 100 ± 31 47 ± 7 21 ± 1
0.03 - 53 ± 8 -3°
40
O
N
~, 20
1000
TABLE II
FIGURE 3 Internalization of "'I-ASOR by hepatoma cells in the
presence of chloroquine and primaquine. Hepatoma cells were
rinsed and incubated for 2 h at 4'C with a saturating concentration
of 1211-ASOR (50 nM) in the presence of no drug (O), 200 uM
chloroquine (A), or 200 uM primaquine (p). Appropriate control
samples contained excess unlabeled ASOR. Unbound 1211-ASOR
was removed by washing and the cells were rapidly temperature-
shifted to 37°C in the presence of the appropriate drugs for the
indicated times. Thereafter, the cells at 4°C were incubated at 4°C
with 10 mM EDTA to release surface-bound 1211-ASOR. Both EDTA-
nonreleasable 1211 (upper panel) as well as EDTA-releasable 1211
(lower panel) were determined. The results have been corrected
for nonspecific binding and represent the mean of triplicate deter-
minations.
N
0 2 4 6 8 10
Time (min,37°C)
Reversibility of the Effects of Primaquine on Uptake of "'I-
ASOR by Hepatoma Cells
Cells were washed and preincubated for 30 min at 37'C in the absence or
presence of 0.2 mM primaquine. After washing, the cells were incubated for
2 h at 37°C with 1251-ASOR in the presence of 0.02 or 0.2 mM primaquine
or 0.2 mM chloroquine or no drug. Nonspecific uptake was determined and
the results are expressed as percent control specific binding ± SEM for three
determinations.
TABLE III
Simultaneous Effects of Primaquine on Surface Binding, Uptake,
and Degradation of 12'1-ASOR by Hepatoma Cells at 4 H
Cells were rinsed and incubated at 37°C for 30 min with various concentra-
tions of primaquine. Thereafter, in the continued presence of the prima-
quine, saturation binding of "'I-ASOR at 4°C or uptake (total cell-associ-
ated) and degradation of "'I-ASOR at 4 h, 37°C, was assessed as described
in the text. Each value is the mean oftriplicate determinations with a range
±10%.
* Internal = (total cell-associated - surface bound).
' The numbers in parentheses are normalized such that 0 M primaquine
equals 1 .00.
tial increase in internal ligand (150% control) (Table III).
Additional studies performed at 20 h demonstrated a similar
increase (150% control) in internal 121I-ASOR in the presence
of 60 MM primaquine (data not presented). These studies
demonstrate an accumulation of undegraded ligand and sug-
gest that the major effect of these agents is on inhibition of
ligand degradation.
We could directly assess the mechanism(s) responsible for
the loss of '21I-ASOR surface binding. Hepatoma cells were
incubated at 37*C with chloroquine or primaquine in order
to reduce surface binding to -30% ofthe control value. Under
these conditions the affinity (Kd) of "'I-ASOR binding was
unaltered (data not presented). These data suggest that the
loss ofsurface binding was not the result of altered affinity of
receptor-ligand binding.
To examine directly whether the loss ofcell surface binding
of ASOR was the result of inactivation of surface ASGP-R
(i.e., it was no longer capable of binding ligand) or whether
surface ASGP-R were no longer present at the cell surface,
we assessed the effect of the drugs by two independent meth-
ods: immunoprecipitation of cell surface receptors after bio-
synthetic labeling and immunoprecipitation of total cell re-
ceptors aftercell surface iodination. HepG2 cellswere labeled
with ["S]methionine by incubation for 60 min, followed by
a 2-h chase with unlabeled methionine. These conditions
allow the newly labeled receptor molecules to reach the cell
surface (18). The cells were then treated for 30 min at 37°C
with 200 /AM chloroquine or primaquine. In one set ofdishes,
the total receptor from the entire cell lysate was immunopre-
cipitated with anti-receptor antibody. As seen in Fig. 4 a, there
was no difference in the amount of total cell receptor immu-
noprecipitated by anti-human ASGP-R antibody in the drug-
treated or control cells. Approximately 95% of the labeled
receptor migrated at an apparent molecular weight of 46,000,
which is the molecular weight ofthe mature receptor, whereas
<5% of the labeled receptor was of an apparent molecular
weight of 40,000, the predominant intracellular precursor
(18). After only the surface receptor was immunoprecipitated,
as seen in Fig. 4b, a radiolabeled receptor of 46,000 mol wt
was identified in the control cells. There was a substantial
reduction in the immunoprecipitable surface receptor from
cells treated with either 200 uM chloroquine (-20% control
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"'I-ASOR (ng/well)
Prima-
quine
tam
Surface
bound
Total cell-
associated Internal*
Degraded
(media)
0 6.4 29.3 22.9 (1 .00)3 13.8 (1 .00)*
20 4.8 39.3 34.5(l .51) 10.4 (0.75)
40 3.9 40.4 36.5(l .59) 7.3 (0.53)
70 3.8 38.1 34.3(l .50) 4.6 (0.33)
100 2.1 33.8 31 .7(l .38) 2.0 (0.14)
200 0.1 2.7 2.6 (0.11) 1 .2 (0.09)
Preincubation drug Uptake incubation drug 2-h uptake
mm MM %
None None 100±5
Primaquine (0.2) Primaquine (0.2) 8±5
Primaquine (0.2) None 94±5
Primaquine (0.2) Primaquine (0.02) 101 ± 10
Primaquine (0.2) Chloroquine (0.2) 29±2FIGURE 4
￿
Effect of chloroquine and primaquine on hepatoma cell
surface and total cell ASGP-R . Hepatoma cells were labeled with
[35S]methionine for 1 h and chased with excess unlabeled methio-
nine for2 h . Sets of dishes were then incubated for 30 min at 37°C
with no drug (a), 200AM chloroquine (b), or 200 uM primaquine
(c) . Thereafter, some dishes were solubilized and total cell receptor
was isolated by immunoprecipitation (A), or cell surface receptor
was isolated by binding antireceptor antibody to the cell surface at
4°C as described in the text (e) . Equal aliquots of cell extract were
processed identically in A and 8, however the concentration of
affinity purified antibody used for surface binding was 40% of
maximal (15 Ag/ml) . The immunoprecipitates were analyzed by
SDS PAGE and autoradiography . Large arrow, 46,000 daltons ; small
arrow, 40,000 daltons . Molecular weight markers are indicated at
right (top to bottom : 93, 68, 46, and 30 kdaltons) .
level) or 200 AM primaquine (~10-15% control level) . As
expected, there was no surface receptor of 40,000 mol wt .
Immunoprecipitation ofsurface receptors allows a quanti-
tative determination of receptor at the cell surface . As seen in
Fig . 5, after primaquine incubation there is a decrease in
immunoprecipitable surface receptor that parallels the loss of
ligand binding sites (Fig. 2) . This is seen at anti-receptor
antibody concentrations of 5-60 Ag/ml (Kd 20-30 Ag/ml)
(Figs. 4 b and 5 ; unpublished data) . An independent assess-
ment ofthe presence of surface receptor after incubation with
primaquine is seen in Fig . 6 . After preincubation in the
absence or presence of 200 AM primaquine for 30 min at
37°C, cell surface proteins were labeled with 121 1 at 4°C.
Analysis of total cell receptor after immunoprecipitation re-
veals a single receptor species at 46,000 mol wt in the control
cells, while cells preincubated with primaquine display a
dramatic reduction in the 46,000-mol wt receptor (Fig . 6).
In HepG2 cells there is a marked ligand-induced depletion
ofcell surface receptors (6). In the presence ofASGP, there is
a rapid depletion of surface ASGP-R . This is followed by a
rapid reappearance of surface receptors that originate for the
most part from the pool of surface receptors that had inter-
nalized and recycled (6) . Therefore, we examined the effect
of chloroquine and primaquine on this ligand-induced recy-
cling of the ASGP-R. As seen in Fig. 7, in the presence of
ASOR at 37°C there is a very rapid loss (t  2 2.5-3 min) of
cell surface binding in the presence ofchloroquine . This initial
rate (first 2 min) of loss of surface binding is unaltered by the
73 6
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FIGURE 5 Effect of primaquine concentration on cell surface
ASGP-R. Hepatoma cells were labeled with ["S]methionine for 1 h
and chased with excess methionine for 2 h . Cells were then incu-
bated with various concentrations of primaquine at 37°C for 30
min . Thereafter, cell surface receptor was isolated by binding anti-
receptor antibody (lanes b-d, 20 kg/ml; lanes e-g 40 wg/ml; lane
a, 20 Fig/ml normal rabbit IgG) to the cell surface at4°Cas described
in the text . Lanes a, b, and e = 0 AM primaquine ; lanes c and f =
80 ELM primaquine ; lanes d and g = 200AM primaquine . Molecular
weight markers are indicated at right (top to bottom = 93, 68, 46,
and 30 kdaltons) .
presence of the amine (Fig. 7) . However, the rapid return of
surface binding to control levels is abrogated by the presence
of amine (Fig . 7), i.e., there is a continued rapid loss of cell
surfaceASGP-R in the presence ofamine . The loss of surface
binding in the presence of amine and ligand is more rapid
than that seen in the presence of amine alone (Figs . 1 and 7).
DISCUSSION
The lysosomotropic agents chloroquine and primaquine in-
hibit receptor-mediated endocytosis ofASGPs in human hep-
atoma HepG2 cells . In studies performed in the absence of
added ASGP, there is a dose-dependent and reversible loss of
cell surface ligand binding sites, ligand uptake, and degrada-
tion. However, there is no effect ofthese agents on binding of
ligand to surface receptor or on internalization of surface-
bound ligand . These observations are consistent with earlier
studieson the effects oflysosomotropic agents on the receptor-
mediated endocytosis of ASGPs in isolated rat hepatocytes
(8, 21), as well as lysosomal enzymes, mannosyl-terminated
proteins, low-density lipoproteins, alpha-2-macroglobulin-
protease complexes, chorionic gonadotropin, and insulin in a
variety of cell types (9-12, 17, 22-24).
The concentrations of chloroquine and primaquine used
for the most part in the present study (20-200AM) are similar
to those required to achieve significant reduction in receptor-mediated endocytosis ofmany ligands (e.g ., low-density lipo-
protein [LDL], mannosyl-terminated albumin, alpha-2-mac-
roglobulin-protease) (10-12).
The mechanism of action of the lysosomotropic agents has
been the subject of intensive investigation . This class of drugs
inhibits lysosomal cathepsins and protein degradation (25,
26), neutralizes lysosomal pH (13, 27), and neutralizes endo-
somal pH (14, 16) . Many of the actions of these agents may
be directly attributable to protonation within acidic intracel-
lular compartments (27) .
Intracellular accumulation of ligand was found at inter-
mediate concentrations of primaquine (20-70,uM), concen-
trations at which ligand degradation was reduced by 75%,
while surface binding was reduced only40% (Table III) . Basu
et al. (12) have also reported similar effects of chloroquine on
intracellular accumulation ofLDL in fibroblasts . Indeed, they
demonstrated that at 50-200 uM chloroquine, intracellular
ligand accumulated to 150-200% of control values, while
degradation decreased to <5% control . Cell surface ligand
binding decreased to <50% control . These observations sug-
FIGURE 6 Effect of prima-
quine on cell surface ASGP-R
following vectorial "51odina-
tion . Hepatoma cells were in-
cubated for 30 min at 37°C in
media in the absence (lane a)
or presence (lane b) of 200,uM
primaquine . Following rinsing
in PBS at 4°C, the cells were
labeled with '25 1 at 4°C and
solubilized as described in the
text. Thetotal cell extractwas
immunoprecipitated with an-
tireceptor antibody and ana-
lyzed by SDS PAGE . Molecu-
lar weight markers are indi-
cated at right (top to bottom ;
93, 68, 46, and 30 kdaltons) .
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FIGURE 7 Effect of chloroquine on the surface binding of
'251-
ASOR to the hepatoma ASGP-R in the presence of ligand . Hepa-
toma cells were rinsed and incubated 2 h at 4°C in the absence
(dashed lines) or presence of 2 leg unlabeledASOR/ml (solid lines) .
Thereafter unbound ASOR was removed and the cells incubated
at 37°C in the absence (O)or presence (0, M) of 1 mM chloroquine .
At the appropriate time, the cellswere rapidly (<5 s) chilled to 4°C .
Surface ASOR was removed by incubation for 5 min at 4°C in PBS/
10mM EDTA . Cell surface binding siteswere then saturated (2 Ag/
ml, 4°Cx 2 h) with '251-ASOR . Each point is the mean of triplicate
determinations of specific binding .
gest that at least two processes are involved in inhibition of
receptor-mediated uptake and degradation by primaquine.
The effect of these agents on the lysosomal degradation of
ligands appears to be the more sensitive process, while loss of
cell surface binding occurs at higher drug concentrations . It
is presently unclear whether neutralization of lysosomal pH
alone is sufficient to account for the reduction in ligand
degradation observed with these agents.
The loss of cell surface binding sites seen in the presence of
chloroquine or primaquine and in the absence of ligand may
have resulted from (a) altered affinity ofligand-receptorbind-
ing, (b) inactivation (i.e., loss of binding activity) of receptor
while still at the cell surface, or (c) loss of the receptor from
the cell surface . The first possibility appears unlikely since
there was no apparent alteration in receptorKd . The latter
two possibilities were examined directly using receptor-label-
ing (both cell surface'"-iodination and biosynthetic labeling)
and anti-receptor antibodies . It was found that in the presence
of chloroquine or primaquine there was a loss of ASGP-R
from the cell surface, while the total cell ASGP-R was unal-
tered (Figs . 4-6) . Thus, surface receptor is sequestered within
the cell . The intracellular site of receptor sequestration is not
presently known ; however, the availability of antireceptor
antibodies and colloidal gold immunocyto-electron micros-
copy (7) will allow this question to be directly examined .
These results are not fully consistent with the findings of
Fiete et al . (28) . These authors were unable to demonstrate a
loss of ASGP-R from the cell surface after treatment with
monensin, although ligand binding activity decreased. How-
ever, the loss ofASGP-R from the cell surface of hepatoma
cells in the presence of lysosomotropic agents is similar to
that observed by Harford et al . (29) in rat hepatocytes treated
with monensin . They demonstrated intracellular (endosomal)
accumulation of ligand binding sites coincident with loss of
ASGP-R from the cell surface .
The notion that constitutive recycling of the ASGP-R oc-
curs in hepatoma cells is supported by two observations . First,
in the absence of ligand the lysosomotropic amines induce a
loss of surface receptor into an internal pool . Second, the
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and in the presence of ligand. These studies suggest that the
constitutive rate of ASGP-R recycling may be -35-50%Q112
5.5-6 min vs. 2.5-3 min) that seen in the presence of ligand
(Fig. 7). However, it is not known whether in the absence of
ligand these agents induce receptor loss by increasing the rate
of unoccupied receptor internalization or by decreasing the
rate of receptor return to the surface or both. Nonetheless,
the presence of ligand itselfinduces a rapid and transient loss
of surface ASGP-R in hepatoma HepG2 cells (Fig. 7) (6). The
presence of lysosomotropic amines has no effect on the very
rapid ligand-induced loss of surface receptors, but it inhibits
the rapid return ofreceptors to the cell surface (Fig. 7). These
findings demonstrate that endocytosis of the ASGP-R itselfis
not altered by the amines, but that these agents diminish or
prevent the reappearance of internalized receptors.
Thus, it appears that the lysosomotropic agents' effect on
ASGP-R recycling most likely involves a substantial decrease
in the rate of receptor return from an intracellular pool.
Similarly, Ciechanover et al. (30) have recently demonstrated
that ammonium chloride decreases the rate of return to the
cell surface of transferrin and the transferrin receptor in
HepG2 cells.
The concept of constitutive recycling of receptors involved
in receptor-mediated endocytosis has evolved from the studies
ofTolleshaugand Berg (8), Kaplan and Keogh (10), Tietze et
al. (17), and Brown et al. (31). In general, these studies have
used various agents, including the amines and carboxylic
ionophores, to demonstrate loss ofsurface ligand binding sites
in the absence of ligand. In addition, Brown et al. (31)
provided evidence for the intracellular trapping of LDL re-
ceptors in studies with anti-LDL receptor antibody and im-
munofluorescence. The present studies with the ASGP-R
support these observations and provide evidence that the
amines interrupt constitutive receptor recycling by diminish-
ing the rate ofreappearance ofinternalized receptor. Although
the mechanism responsible for this observation is not known,
acidification within endosomal compartments (16, 32) may
be obligatory for receptor reappearance at the cell surface.
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